
From Global Health to Climate: Shaping Markets Across Sectors, with Dai Ellis
with Dai Ellis
About this episode
Today’s guest is Dai Ellis, founder and CEO of Cascade Climate. Dai spent his career creating and accelerating the development of systems and markets in multiple sectors – first in global health, then in education, and now climate tech.
In this episode, Dai tells host Inder Singh all about the work he and his team at Cascade are doing to orchestrate markets for innovations that will help stabilize our climate. He also reveals the key lessons he learned from his time at CHAI leading groundbreaking work that reduced the price of life-saving medicines, and how he’s imported those lessons to the climate sector.
Dai and Inder dig into the market shaping tools he honed in global health to tackle climate issues, the critical role of market orchestrators in driving large-scale systemic change, and how someone could create that role in a new sector.
The interview was recorded in May 2025.
Episode quotes
Click a timestamp to jump straight to it in the player.
The stance of a market shaper is fundamentally to occupy a middle ground on that question: to neither, capitalism is what's causing this problem in the first place, which is not without any truth obviously, nor at the other end of the spectrum to say, markets will solve this. To choose to be a market shaper is to say there's truth in both of those things, that, like, there's truth in the idea that markets are a powerful way to organize incentives and organize human behavior and action toward outcomes, and they're deeply flawed when left unattended and unregulated in terms of, you know, what outcomes you are going to see from that.
You have to have power to market shape, but it's not just financial power or government power, like hard power. A lot of it is soft power. How do we assemble soft power and other forms of, you know, influence and steerability? And then how do we put that to work, and coordinate efforts to get us more quickly from place A to place B?
I think Cascade is very explicitly trying to offer itself up as an orchestrator for specific market shaping initiatives. Your ability to orchestrate is fundamentally targeted or limited. But you're trying to do that in high… Oh, I hate the word leverage, but highly leveraged, wise.
Keep listening
More from the show
All episodes →
Volume Guarantees and the High-Price, Low-Volume Trap with Hema Srinivasan
Hema SrinivasanHema Srinivasan, formerly the Chief Access Officer of MedAccess, a leader of CHAI’s market shaping work, and a former country director for a major pharma company, joins host Inder Singh to discuss how market shaping in g…

CHAI's Approach to Cost Plus Negotiations with Aaron Patillo
Aaron PatilloAaron Patillo was a key member of the Clinton Health Access Initiative's (CHAI) original drug access team. Based in Beijing, he brokered deals with pharmaceutical companies that helped slash the price of HIV/AIDS medicin…

Local versus Global Market Shaping with Oliver Sabot
Oliver SabotWhen it comes to market shaping, having a wide range of tools in your kit is critical. “You don’t want to be a hammer looking for a nail,” says today’s guest Oliver Sabot. Sabot has spent years shaping markets in various…